Site CN86005
Site CN86005
Ürümqi, China1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) | Metastatic Hormone Sensitive Prostate Cancer | Active, not recruiting | Phase 3 | 2026-09-16 | NCT04076059 |